4.5 Article

Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparison

期刊

PROTEOMICS
卷 9, 期 1, 页码 74-86

出版社

WILEY
DOI: 10.1002/pmic.200800417

关键词

False discovery rate; Mass spectrometry; Power; Sample size; Type I error

资金

  1. Cancer Research UK
  2. MRC [G0500994, G9900432, G0800808] Funding Source: UKRI
  3. Medical Research Council [G0500994, G0800808, G9900432] Funding Source: researchfish

向作者/读者索取更多资源

Mass spectrometric profiling approaches such as MALDI-TOF and SELDI-TOF are increasingly being used in disease marker discovery, particularly in the lower molecular weight proteome. However, little consideration has been given to the issue of sample size in experimental design. The aim of this study was to develop a protocol for the use of sample size calculations in proteomic profiling studies using MS. These sample size calculations can be based on a simple linear mixed model which allows the inclusion of estimates of biological and technical variation inherent in the experiment. The use of a pilot experiment to estimate these components of variance is investigated and is shown to work well when compared with larger studies. Examination of data from a number of studies using different sample types and different chromatographic surfaces shows the need for sample- and preparation-specific sample size calculations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据